NTRA vs. EXAS, DGX, LH, FTRE, RDNT, SRPT, SOLV, UTHR, UHS, and SNN
Should you be buying Natera stock or one of its competitors? The main competitors of Natera include Exact Sciences (EXAS), Quest Diagnostics (DGX), Laboratory Co. of America (LH), Fortrea (FTRE), RadNet (RDNT), Sarepta Therapeutics (SRPT), NYSE:SOLV (SOLV), United Therapeutics (UTHR), Universal Health Services (UHS), and Smith & Nephew (SNN). These companies are all part of the "medical" sector.
Natera (NASDAQ:NTRA) and Exact Sciences (NASDAQ:EXAS) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment, community ranking and earnings.
Natera has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, Exact Sciences has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500.
Natera currently has a consensus target price of $86.40, suggesting a potential downside of 8.14%. Exact Sciences has a consensus target price of $97.44, suggesting a potential upside of 63.79%. Given Exact Sciences' higher probable upside, analysts plainly believe Exact Sciences is more favorable than Natera.
Exact Sciences has a net margin of -8.17% compared to Natera's net margin of -40.16%. Exact Sciences' return on equity of -6.60% beat Natera's return on equity.
99.9% of Natera shares are owned by institutional investors. Comparatively, 88.8% of Exact Sciences shares are owned by institutional investors. 9.4% of Natera shares are owned by company insiders. Comparatively, 1.3% of Exact Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Exact Sciences has higher revenue and earnings than Natera. Exact Sciences is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks.
In the previous week, Natera had 18 more articles in the media than Exact Sciences. MarketBeat recorded 22 mentions for Natera and 4 mentions for Exact Sciences. Exact Sciences' average media sentiment score of 1.06 beat Natera's score of 0.20 indicating that Exact Sciences is being referred to more favorably in the news media.
Exact Sciences received 495 more outperform votes than Natera when rated by MarketBeat users. Likewise, 72.40% of users gave Exact Sciences an outperform vote while only 68.59% of users gave Natera an outperform vote.
Summary
Exact Sciences beats Natera on 10 of the 18 factors compared between the two stocks.
Get Natera News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
